FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Aharona Glatman-Freedman

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Procedures

Physiology

Antibody Specificity

Anatomy

Lung

Co-author Network

Publications

TOP 3
Aharona Glatman-Freedman; Katherine Nichols
The effect of social determinants on immunization programs.
Aharona Glatman-Freedman; Lewis R Goldfrank; Susan K Jacobs; Justin I Mathew; Ian Portelli; Jonathan E Slutzman; Silas W Smith
Attack rates assessment of the 2009 pandemic H1N1 influenza A in children and their contacts: a systematic review and meta-analysis.
Rafael Prados-Rosales; Andres Baena; Luis R Martinez; Jose Luque-Garcia; Rainer Kalscheuer; Usha Veeraraghavan; Carmen Camara; Joshua D Nosanchuk; Gurdyal S Besra; Bing Chen; Juan Jimenez; Aharona Glatman-Freedman; William R. Jacobs Jr.; Steven A Porcelli; Arturo Casadevall
Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Aharona Glatman-Freedman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Aharona Glatman-Freedman; Katherine Nichols
The effect of social determinants on immunization programs.
Human vaccines & immunotherapeutics 2012;8(3):293-301.
2012: Aharona Glatman-Freedman; Lewis R Goldfrank; Susan K Jacobs; Justin I Mathew; Ian Portelli; Jonathan E Slutzman; Silas W Smith
Attack rates assessment of the 2009 pandemic H1N1 influenza A in children and their contacts: a systematic review and meta-analysis.
PloS one 2012;7(11):e50228.
2011: Rafael Prados-Rosales; Andres Baena; Luis R Martinez; Jose Luque-Garcia; Rainer Kalscheuer; Usha Veeraraghavan; Carmen Camara; Joshua D Nosanchuk; Gurdyal S Besra; Bing Chen; Juan Jimenez; Aharona Glatman-Freedman; William R. Jacobs Jr.; Steven A Porcelli; Arturo Casadevall
Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice.
The Journal of clinical investigation 2011;121(4):1471-83.
2010: Aharona Glatman-Freedman; Mary-Louise Cohen; Katherine A Nichols; Robert F Porges; Ivy Rayos Saludes; Kevin Steffens; Victor G Rodwin; David W Britt
Factors affecting the introduction of new vaccines to poor nations: a comparative study of the Haemophilus influenzae type B and hepatitis B vaccines.
PloS one 2010;5(11):e13802.
2007: W Ray Waters; Mitchell V Palmer; Brian J Nonnecke; Tyler Thacker; Charles F C Scherer; D Estes; William R. Jacobs Jr.; Aharona Glatman-Freedman; Michelle H. Larsen
Failure of a Mycobacterium tuberculosis DeltaRD1 DeltapanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: comparisons to responses elicited by M. bovis bacille Calmette Guerin.
Vaccine 2007;25(45):7832-40.
2007: Ban Al-Sayyed; Sajida Piperdi; Xinni Yuan; Anping Li; Gurdyal S Besra; William R. Jacobs Jr.; Arturo Casadevall; Aharona Glatman-Freedman
Monoclonal antibodies to Mycobacterium tuberculosis CDC 1551 reveal subcellular localization of MPT51.
Tuberculosis (Edinburgh, Scotland) 2007;87(6):489-97.
2007: Jacqueline M Achkar; Arturo Casadevall; Aharona Glatman-Freedman
Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches.
Expert review of anti-infective therapy 2007;5(3):461-74.
2007: Jennifer I.M. Davis; Wang Yong Zheng; Aharona Glatman-Freedman; Josephine Anne Navoa Ng; Marimel R Pagcatipunan; Herschel Lessin; Arturo Casadevall; David Goldman
Serologic evidence for regional differences in pediatric cryptococcal infection.
The Pediatric infectious disease journal 2007;26(6):549-51.
2006: Aharona Glatman-Freedman
The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy.
Tuberculosis (Edinburgh, Scotland) 2006;86(3-4):191-7.
2006: Mark L Lang; Aharona Glatman-Freedman
Do CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis?
Infection and immunity 2006;74(2):803-9.
2005: Gillian A Lang; Petr A Illarionov; Aharona Glatman-Freedman; Gurdyal S Besra; Mark L Lang
BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments.
International immunology 2005;17(7):899-908.
2004: Aharona Glatman-Freedman; Arturo Casadevall; Zongdong Dai; William R. Jacobs Jr.; Anping Li; Sheldon L Morris; Josepine Anne D Navoa; Sajida Piperdi; John B Robbins; Rachel Schneerson; J Reid Schwebach; Michael Shapiro
Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan.
Journal of clinical microbiology 2004;42(7):3225-31.
2003: Aharona Glatman-Freedman
Advances in antibody-mediated immunity against Mycobacterium tuberculosis: implications for a novel vaccine strategy.
FEMS immunology and medical microbiology 2003;39(1):9-16.
2003: Josephine Anne D Navoa; Suman Laal; Liise-anne Pirofski; Gary R McLean; Zhongdong Dai; John B Robbins; Rachel Schneerson; Arturo Casadevall; Aharona Glatman-Freedman
Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan.
Clinical and diagnostic laboratory immunology 2003;10(1):88-94.
2002: J Reid Schwebach; Bing Chen; Aharona Glatman-Freedman; Arturo Casadevall; John D McKinney; John L Harb; Patrick J McGuire; W Emmett Barkley; Barry R Bloom; William R. Jacobs Jr.
Infection of mice with aerosolized Mycobacterium tuberculosis: use of a nose-only apparatus for delivery of low doses of inocula and design of an ultrasafe facility.
Applied and environmental microbiology 2002;68(9):4646-9.
2002: J Reid Schwebach; Aharona Glatman-Freedman; Leslie Gunther-Cummins; Zhongdong Dai; John B Robbins; Rachel Schneerson; Arturo Casadevall
Glucan is a component of the Mycobacterium tuberculosis surface that is expressed in vitro and in vivo.
Infection and immunity 2002;70(5):2566-75.
2002: Aharona Glatman-Freedman
Rubella vaccine.
Pediatrics in review / American Academy of Pediatrics 2002;23(3):106-7; discussion 106-7.
2001: J Reid Schwebach; Arturo Casadevall; Rachel Schneerson; Zhongdong Dai; X Wang; John B Robbins; Aharona Glatman-Freedman
Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo.
Infection and immunity 2001;69(9):5671-8.
2000: Aharona Glatman-Freedman; Aron Mednick; Nikoletta Lendvai; Arturo Casadevall
Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M.
Infection and immunity 2000;68(1):335-41.
1998: R Teitelbaum; Aharona Glatman-Freedman; Bing Chen; John B Robbins; E Unanue; Arturo Casadevall; Barry R Bloom
A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(26):15688-93.
1998: Aharona Glatman-Freedman; Arturo Casadevall
Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis.
Clinical microbiology reviews 1998;11(3):514-32.
1998: Arturo Casadevall; Wendy Cleare; Marta Feldmesser; Aharona Glatman-Freedman; David Goldman; Thomas R Kozel; Nikoletta Lendvai; J Mukherjee; Liise-anne Pirofski; J Rivera; AL Rosas; Matthew D Scharff; Philippe Valadon; K Westin; Z Zhong
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.
Antimicrobial agents and chemotherapy 1998;42(6):1437-46.